FindTrial
Sign In

mycophenolate mofetil (Cellcept)

DRUG7 trials

Sponsors

University of Texas Southwestern Medical Center, Children's Hospital Medical Center, Cincinnati, University of Washington, Aaron Boster, Hoffmann-La Roche

Conditions

Diabetic NephropathiesGlomerulonephritis, IGAHypertension, RenalKidney Failure, ChronicKidney TransplantMultiple SclerosisMyasthenia Gravis, GeneralizedStable Renal Transplant Recipients

Early Phase 1

Combination Therapy Using Cellcept and Rebif in RRMS
CompletedNCT00618527
Aaron BosterMultiple Sclerosis
Start: 2006-08-31End: 2012-05-31Updated: 2012-11-15

Phase 1

Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
TerminatedNCT00433953
Children's Hospital Medical Center, CincinnatiKidney Transplant
Start: 2007-02-28End: 2010-02-28Updated: 2013-02-20

Phase 2

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
CompletedNCT00223301
University of Texas Southwestern Medical CenterMultiple Sclerosis
Start: 2004-07-31End: 2007-03-31Target: 24Updated: 2013-04-22
Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
CompletedNCT00324506
University of Texas Southwestern Medical CenterMultiple Sclerosis
Start: 2006-05-31End: 2009-06-30Updated: 2013-06-19
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
CompletedNCT00446459
University of WashingtonDiabetic Nephropathies, Glomerulonephritis, IGA, Hypertension, Renal +1
Start: 2006-04-30End: 2008-12-31Updated: 2010-04-15

Phase 3

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
CompletedNCT00683969
Hoffmann-La RocheMyasthenia Gravis, Generalized
Start: 2004-08-31End: 2007-05-31Target: 136Updated: 2008-05-26

Phase 4

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients
TerminatedNCT00991510
Teva Branded Pharmaceutical Products R&D, Inc.Stable Renal Transplant Recipients
Start: 2009-08-31End: 2010-10-31Updated: 2018-11-08